盤龍藥業(002864.SZ)擬向銀行申請授信額度1億元
格隆匯5月18日丨盤龍藥業(002864.SZ)公佈,公司於2020年5月16日召開了公司第三屆董事會第六次會議,會議審議通過了《關於公司向中國農業發展銀行柞水縣支行申請授信額度人民幣10,000萬元的議案》,具體情況如下:
根據公司生產經營需要和資金週轉需要,公司擬向中國農業發展銀行柞水縣支行申請授信額度人民幣1億元,授信期限為一年,具體授信額度以銀行審批為準,並授權公司管理層負責辦理在上述額度範圍內簽署相關合同文件及其他法律文件。具體融資金額視公司實際資金需求和銀行審批情況確定,授信期限內,授信額度可循環使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.